Invention Grant
- Patent Title: Phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition
-
Application No.: US14348799Application Date: 2012-09-25
-
Publication No.: US09963482B2Publication Date: 2018-05-08
- Inventor: Ken Saijo , Chikashi Ishioka , Tadashi Katoh
- Applicant: Tohoku University
- Applicant Address: JP Miyagi
- Assignee: Tohoku University
- Current Assignee: Tohoku University
- Current Assignee Address: JP Miyagi
- Agency: Osha Liang LLP
- Priority: JP2011-217378 20110930
- International Application: PCT/JP2012/074542 WO 20120925
- International Announcement: WO2013/047509 WO 20130404
- Main IPC: A61K38/06
- IPC: A61K38/06 ; C07K5/12 ; C07K5/103 ; A61K38/00
Abstract:
A substance contains a phosphatidylinositol-3-kinase (PI3K) inhibitor including a depsipeptide-class compound represented by formula (1), or a physiologically acceptable salt thereof that combines a PI3K inhibitory effect and an HDAC inhibitory effect to provide an anti-cancer pharmaceutical composition for the treatment of an intractable cancer.
Public/Granted literature
- US20140235821A1 NOVEL PHOSPHATIDYLINOSITOL-3-KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION Public/Granted day:2014-08-21
Information query
IPC分类:
